0Q

Creades publ ABLSE Creades publ Stock Report

Last reporting period 31 Mar, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

0.264

Micro

Exchange

XLON - London Stock Exchange

0QI9.L Stock Analysis

0Q

Avoid

Based on Eyestock quantitative analysis, 0QI9.L`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

47/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-98.8 %

Greatly overvalued

Market cap $B

0.264

Dividend yield

2.57 %

Shares outstanding

93.1 B

Creades AB operates as an investment company. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2012-02-22. The firm invests in small and medium-sized Swedish companies with objective to create value through development and restructuring. As of February 22, 2012, the Company’s portfolio consisted primarily of listed shares (60%) and unlisted shares (30%). As of February 21, 2012, the Company’s portfolio included shares of such listed companies, as Avanza Bank (29%), Concentric (8%), Haldex (7%), Bilia (6%), Lindab International (4%), eWork Scandinavia (3%), as well as such unlisted companies, as Carnegie (12%), Klarna (6%), GLOBAL Betterier (3%) and Acne Jeans (3%), among others. As of December 31, 2011, the Company was a wholly owned subsidiary of Investment AB Oresund. In July 2013, 30% of the Company's net asset value was transferred to Sedarec AB.

View Section: Eyestock Rating